Literature DB >> 17286745

Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats.

Graciela Letechipía-Vallejo1, Elisa López-Loeza, Verónica Espinoza-González, Ignacio González-Burgos, María Esther Olvera-Cortés, Gabriela Moralí, Miguel Cervantes.   

Abstract

Consensus on neuroprotection has pointed out the relevance of the long-term morphological and functional evaluation of the effectiveness of putative neuroprotective procedures. In the present study, place learning (Morris water maze) and working memory (eight-arm Olton radial maze) were evaluated in adult male rats 90 days after 15 min of global cerebral ischemia (four-vessel occlusion) followed by continuous i.v. infusion (10 mg/kg/hr) of melatonin (Isch + Mel) or vehicle (Isch + Veh) for 6 hr, and the pyramidal neuron population of the cornus Ammoni (CA) of the hippocampus and layers III and V of the medial prefrontal cortex was assessed at the end of the behavioral testing period (120 days after ischemia). Impairment of place learning, a significant delay in working memory acquisition, and a significant loss of pyramidal neurons in the Ammon's horn (CA1: 23%, CA2: 52% CA3: 73%, hilus: 64% remaining neurons), were observed in the Isch + Veh group. By contrast, a similar performance of the Isch + Mel group to that in the Intact and Sham groups and better than that of the Isch + Veh group, besides a significant reduction of pyramidal neuron loss in the CA subfields (CA1: 79%, CA2: 88% CA3: 86%, hilus: 72% remaining neurons), documented that melatonin treatment led to a long-term preservation of both the neural substrate, and the capability for integration of spatial learning and memory, mainly dependent on a normal hippocampal functioning. Overall the results emphasize the efficacy of melatonin in counteracting the pathophysiological processes induced by ischemia, by exerting its actions during a short but critical period early after the ischemic episode.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286745     DOI: 10.1111/j.1600-079X.2006.00395.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  13 in total

Review 1.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 2.  Synergistic neuroprotective therapies with hypothermia.

Authors:  Maria Roberta Cilio; Donna M Ferriero
Journal:  Semin Fetal Neonatal Med       Date:  2010-03-07       Impact factor: 3.926

3.  Hippocampal Deformations and Entorhinal Cortex Atrophy as an Anatomical Signature of Long-Term Cognitive Impairment: from the MCAO Rat Model to the Stroke Patient.

Authors:  C Delattre; C Bournonville; F Auger; R Lopes; C Delmaire; H Henon; A M Mendyk; S Bombois; J C Devedjian; D Leys; C Cordonnier; R Bordet; M Bastide
Journal:  Transl Stroke Res       Date:  2017-10-16       Impact factor: 6.829

4.  Melatonin protects N2a against ischemia/reperfusion injury through autophagy enhancement.

Authors:  Yanchun Guo; Jianfei Wang; Zhongqiang Wang; Yi Yang; Ximing Wang; Qiuhong Duan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

5.  Co-Administration of Progesterone and Melatonin Attenuates Ischemia-Induced Hippocampal Damage in Rats.

Authors:  Azim Hedayatpour; Maryam Shiasi; Hamidreza Famitafreshi; Farid Abolhassani; Parisa Ebrahimnia; Tahmineh Mokhtari; Gholamreza Hassanzaeh; Morteza Karimian; Bashir Nazparvar; Narges Marefati; Masoomeh Dehghan Tarzjani
Journal:  J Mol Neurosci       Date:  2018-09-04       Impact factor: 3.444

6.  Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders.

Authors:  Genaro G Ortiz; Gloria A Benítez-King; Sergio A Rosales-Corral; Fermín P Pacheco-Moisés; Irma E Velázquez-Brizuela
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

7.  Prophylactic Melatonin Treatment Ameliorated Propofol-Induced Cognitive Dysfunction in Aged Rats.

Authors:  Junhua Li; Guiyun Wu; Wen Song; Yafang Liu; Zhixiao Han; Zhiwen Shen; Yujuan Li
Journal:  Neurotox Res       Date:  2020-11-07       Impact factor: 3.911

8.  Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages.

Authors:  Hsiao-Wen Lin; E-Jian Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

9.  Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.

Authors:  G O'Neal-Moffitt; V Delic; P C Bradshaw; J Olcese
Journal:  Mol Neurodegener       Date:  2015-07-11       Impact factor: 14.195

10.  Effects of melatonin on cognitive impairment and hippocampal neuronal damage in a rat model of chronic cerebral hypoperfusion.

Authors:  Choong Hyun Lee; Joon Ha Park; Ji Hyeon Ahn; Moo-Ho Won
Journal:  Exp Ther Med       Date:  2016-04-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.